Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating anxiety while minimizing abuse and dependence

N Sussman1

  • 1Department of Psychiatry, New York University Medical Center, N.Y.

The Journal of Clinical Psychiatry
|May 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychosomatic medicine.

Pennsylvania medical journal (1928)·2010
Same author

Venlafaxine XR therapy for major depression and anxiety disorders. The clinical implications that its advantages pose.

Postgraduate medicine·2009
Same author

Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis.

American journal of physiology. Lung cellular and molecular physiology·2008
Same author

A study of the pharmacokinetic interaction of istradefylline, a novel therapeutic for Parkinson's disease, and atorvastatin.

Journal of clinical pharmacology·2008
Same author

Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
Same author

Background and rationale for use of anticonvulsants in psychiatry.

Cleveland Clinic journal of medicine·2002
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Anxiety medications can be controversial due to abuse and dependence risks. This review explores factors contributing to anxiolytic drug dependence and offers strategies to minimize these risks for safer patient care.

Area of Science:

  • Psychiatry
  • Pharmacology
  • Clinical Psychology

Background:

  • Anxiety disorders are prevalent and can be debilitating.
  • Antianxiety medications offer effective treatment but face controversy.
  • Concerns regarding abuse and dependence associated with anxiolytic drugs are significant.

Purpose of the Study:

  • To address the factors contributing to anxiolytic drug dependence and abuse.
  • To examine patient characteristics and pharmacologic profiles influencing dependence.
  • To provide recommendations for minimizing abuse and dependence risks.

Main Methods:

  • Review of literature on anxiolytic drug dependence and abuse.
  • Analysis of patient-related factors and drug pharmacologies.
  • Development of clinical recommendations for risk mitigation.

Related Experiment Videos

Main Results:

  • Anxiolytic drug dependence and abuse are influenced by patient-specific and drug-specific factors.
  • Concerns about risks can hinder appropriate treatment initiation.
  • Failure to identify dependence can lead to clinical challenges.

Conclusions:

  • Minimizing anxiolytic drug abuse and dependence requires careful diagnostic assessment.
  • Patient education regarding risks and benefits is crucial.
  • Strategic drug selection and comprehensive treatment planning are essential for safe and effective anxiety management.